We are monitoring the impact of COVID-19 on Asia Pacific Cardiac Marker Testing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4806
Share on
Share on

Asia Pacific Cardiac Marker Testing Market Research Report – Segmented By Type, Product, Disease, Testing & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends & Forecasts (2021 to 2026)

Pulished: April, 2021
ID: 4806
Pages: 145

Asia Pacific Cardiac Marker Testing Market Size (2021 to 2026):

The size of the Asia Pacific Cardiac Marker Testing Market is expected to grow at 11.7% CAGR from 2021 to 2026. It is projected that the market is valued at USD 0.44 billion in 2021 and is anticipated to reach USD 0.76 billion by 2026.

The incidence of cardiovascular diseases leading to deaths is very high in the Asia Pacific countries, which is estimated to support the market growth in this region. Y-O-Y growth in cardiac diseases, rise in funds from public and private organizations for research and development activities on cardiac markers are likely to drive the market growth in the region. Moreover, ongoing clinical trials for recognizing new cardiac markers are likely to propel the cardiac marker testing market growth. Key strategies by key players to improve their shares and growing demand to promote effective healthcare products are escalating the need for the Asia Pacific Cardiac Marker Testing Market.

Technical issues relevant to sample collection and storage, regulatory problems, and inadequate reimbursement policies are some factors restricting the cardiac marker testing market in the APAC region. The shortage of skilled professionals is hindering the Asia Pacific Cardiac Marker Testing Market demand.

This research report on the Asia Pacific Cardiac Marker Testing Market has been segmented and sub-segmented into the following categories:

By Type:

  • Troponin I & T
  • CK-MB
  • Myoglobin
  • BNP
  • hs-CRP

By Product:

  • Reagent
  • Instrument
    • Chemiluminescence
    • Immunofluorescence
    • Immunochromatography
    • ELISA

By Disease:

  • Acute Coronary Syndrome
  • Myocardial Infarction
  • Congestive Heart Failure

By Testing:

  • Lab
  • POC

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Regional Analysis:

Among all the regions of the globe, the Asia Pacific region is expected to grow at the fastest rate during the forecast period due to factors like Y-O-Y growth in CVD incidence in countries like India and China and a quick rise in the aging population. Initiatives taken by the public and private companies to bring out awareness regarding the early disease diagnosis are escalating APAC's market growth. China is expected to rule the market shares because of mounting knowledge about advanced technologies among lab professionals and cardiologists due to continuous conferences and seminars. In China, annual cardiovascular events are evaluated to rise by more than 50% from 2010 to 2030. Japan and India have considerable and notable growth in the cardiac marker testing market in APAC. Factors like improving healthcare infrastructure, large patient count, and growing funds and investments for the enhancements of cardiac analyzers are impelling the APAC region's market growth.

Notable companies leading the Asia Pacific Cardiac Marker Testing Market Profiled in the report are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS Roche Diagnostics Ltd., Abbott Laboratories, Siemens AG, Danaher Corporation, Alere Inc., bioMérieux SA, LSI Medience Corporation, Ortho Clinical Diagnostics, Randox Laboratories Ltd, and Guangzhou Wondfo Biotech Co. Ltd.

1.Introduction         

                1.1 Market Definition   

                1.2 Study Deliverables 

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions 

2. Research Methodology                  

                2.1 Introduction      

                2.2 Research Phases     

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview              

                3.1 Executive Summary 

                3.2 Key Inferences

                3.3 Epidemiology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers 

                4.2 Market Restraints   

                4.3 Key Challenges

                4.4 Current Opportunities in the Market     

5. Market Segmentation                     

                5.1 Product       

                                5.1.1 Introduction                                           

                                5.1.2 Reagents and Kits                                

                                5.1.3 Instruments                                           

5.1.3.1 Chemiluminescence                        

5.1.3.2 Immunofluorescence                     

5.1.3.3 Elisa                        

5.1.3.4 Immunochromatography                              

                                5.1.4  Y-o-Y Growth Analysis, By Product                                              

                                5.1.5  Market Attractiveness Analysis, By Product                                            

                                5.1.6  Market Share Analysis, By Product                                              

                5.2 Type     

                                5.2.1 Introduction                                           

                                5.2.2 Troponin I & T                                        

                                5.2.3 CK-MB                                      

                                5.2.4 Myoglobin

                                5.2.5 BNP                                            

                                5.2.6 hsCRP                                        

                                5.2.7 Y-o-Y Growth Analysis, By Type                                     

                                5.2.8 Market Attractiveness Analysis, By Type                                   

                                5.2.9 Market Share Analysis, By Type                                     

                5.3 Disease       

                                5.3.1 Introduction                                           

                                5.3.2 Acute Coronary Syndrome

                                5.3.3 Myocardial Infarction                                         

                                5.3.4 Congestive Heart Failure                                   

                                5.3.5 Y-o-Y Growth Analysis, By Disease

                                5.3.6  Market Attractiveness Analysis, By Disease                                             

                                5.3.7  Market Share Analysis, By Disease                                              

                5.4 Type of Testing        

                                5.4.1 Introduction                                           

                                5.4.2 Lab                                             

                                5.4.3 Point-Of-Care Testing                                        

                                5.4.4 Y-o-Y Growth Analysis, By Type of Testing                                                

                                5.4.5  Market Attractiveness Analysis, By Type of Testing                                             

                                5.4.6  Market Share Analysis, By Type of Testing                                               

6. Geographical Analysis                     

                6.1 Introduction      

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

6.1.3.1 By Geographical Area                     

6.1.3.2 By Product                           

6.1.3.3 By Type                 

6.1.3.4 By Disease                           

6.1.3.5 By Type of Testing                            

                                6.1.4  Market Attractiveness Analysis                                     

6.1.4.1 By Geographical Area                     

6.1.4.2 By Product                           

6.1.4.3 By Type                 

6.1.4.4 By Disease                           

6.1.4.5 By Type of Testing                            

                                6.1.5  Market Share Analysis                                      

6.1.5.1 By Geographical Area                     

6.1.5.2 By Product                           

6.1.5.3 By Type                 

6.1.5.4 By Disease                           

6.1.5.5 By Type of Testing                            

                6.2 China    

                6.3 India     

                6.4 Japan   

                6.5 South Korea      

                6.6 Australia     

                6.7 Rest of APAC

7.Strategic Analysis               

                7.1 PESTLE analysis

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis     

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                

                8.1 Getinge Group 

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Medtronic plc   

                8.3 LivaNova PLC    

                8.4 XENIOS Roche Diagnostics Ltd.  

                8.5 Abbott Laboratories

                8.6 Siemens AG

                8.7 Danaher Corporation    

                8.8 Alere Inc.    

                8.9 BioMérieux SA 

                8.10 LSI Medience Corporation

9.Competitive Landscape                   

                9.1 Market share analysis   

                9.2 Merger and Acquisition Analysis      

                9.3 Agreements, Collaborations, and Joint Ventures

                9.4 New Product Launches

10.Market Outlook and Investment Opportunities                 

Appendix                  

                a) List of Tables 

                b) List of Figures     

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of Type, Product, Disease, and Testing along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the Asia Pacific Market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Cardiac Marker Testing  Market By Type, From 2021 to 2026 ( USD Billion )
  2. Asia-Pacific Troponin I & T Market By Region, From 2021 to 2026 ( USD Billion )
  3. Asia-Pacific Insulin Delivery Market By Region, From 2021 to 2026 ( USD Billion )
  4. Asia-Pacific CK-MB Market By Region, From 2021 to 2026 ( USD Billion )
  5. Asia-Pacific Myoglobin Market By Region, From 2021 to 2026 ( USD Billion )
  6. Asia-Pacific BNP Market By Region, From 2021 to 2026 ( USD Billion )
  7. Asia-Pacific hsCRP Market By Region, From 2021 to 2026 ( USD Billion )
  8. Asia-Pacific Cardiac Marker Testing  Market By Product, From 2021 to 2026 ( USD Billion )
  9. Asia-Pacific Reagent Market By Region, From 2021 to 2026 ( USD Billion )
  10. Asia-Pacific Instrument Market By Region, From 2021 to 2026 ( USD Billion )
  11. Asia-Pacific Chemiluminescence Market By Region, From 2021 to 2026 ( USD Billion )
  12. Asia-Pacific Immunofluorescence Market By Region, From 2021 to 2026 ( USD Billion )
  13. Asia-Pacific Immunochromatography Market By Region, From 2021 to 2026 ( USD Billion )
  14. Asia-Pacific ELISA Market By Region, From 2021 to 2026 ( USD Billion )
  15. Asia-Pacific Cardiac Marker Testing  Market By Disease, From 2021 to 2026 ( USD Billion )
  16. Asia-Pacific Acute Coronary Syndrome Market By Region, From 2021 to 2026 ( USD Billion )
  17. Asia-Pacific Myocardial Infarction Market By Region, From 2021 to 2026 ( USD Billion )
  18. Asia-Pacific Congestive Heart Failure Market By Region, From 2021 to 2026 ( USD Billion )
  19. Asia-Pacific Cardiac Marker Testing  Market By Testing, From 2021 to 2026 ( USD Billion )
  20. Asia-Pacific Lab Market By Region, From 2021 to 2026 ( USD Billion )
  21. Asia-Pacific POC  Market By Region, From 2021 to 2026 ( USD Billion )
  22. Japan Cardiac Marker Testing  Market By Type, From 2021 to 2026 ( USD Billion )
  23. Japan Cardiac Marker Testing  Market By Product, From 2021 to 2026 ( USD Billion )
  24. Japan Cardiac Marker Testing  Market By Disease, From 2021 to 2026 ( USD Billion )
  25. Japan Cardiac Marker Testing  Market By Testing, From 2021 to 2026 ( USD Billion )
  26. China Cardiac Marker Testing  Market By Type, From 2021 to 2026 ( USD Billion )
  27. China Cardiac Marker Testing  Market By Product, From 2021 to 2026 ( USD Billion )
  28. China Cardiac Marker Testing  Market By Disease, From 2021 to 2026 ( USD Billion )
  29. China Cardiac Marker Testing  Market By Testing, From 2021 to 2026 ( USD Billion )
  30. India Cardiac Marker Testing  Market By Type, From 2021 to 2026 ( USD Billion )
  31. India Cardiac Marker Testing  Market By Product, From 2021 to 2026 ( USD Billion )
  32. India Cardiac Marker Testing  Market By Disease, From 2021 to 2026 ( USD Billion )
  33. India Cardiac Marker Testing  Market By Testing, From 2021 to 2026 ( USD Billion )
  34. Australia Cardiac Marker Testing  Market By Type, From 2021 to 2026 ( USD Billion )
  35. Australia Cardiac Marker Testing  Market By Product, From 2021 to 2026 ( USD Billion )
  36. Australia Cardiac Marker Testing  Market By Disease, From 2021 to 2026 ( USD Billion )
  37. Australia Cardiac Marker Testing  Market By Testing, From 2021 to 2026 ( USD Billion )
  38. South Korea Cardiac Marker Testing  Market By Type, From 2021 to 2026 ( USD Billion )
  39. South Korea Cardiac Marker Testing  Market By Product, From 2021 to 2026 ( USD Billion )
  40. South Korea Cardiac Marker Testing  Market By Disease, From 2021 to 2026 ( USD Billion )
  41. South Korea Cardiac Marker Testing  Market By Testing, From 2021 to 2026 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample